Dawson VL - Search Results

1

Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease.

Brahmachari S, Lee S, Kim S, Yuan C, Karuppagounder SS, Ge P, Shi R, Kim EJ, Liu A, Kim D, Quintin S, Jiang H, Kumar M, Yun SP, Kam TI, Mao X, Lee Y, Swing DA, Tessarollo L, Ko HS, Dawson VL, Dawson TM. Brahmachari S, et al. Among authors: dawson vl, dawson tm. Brain. 2019 Aug 1;142(8):2380-2401. doi: 10.1093/brain/awz172. Brain. 2019. PMID: 31237944 Free PMC article.

2

A novel neuronal messenger molecule in brain: the free radical, nitric oxide.

Dawson TM, Dawson VL, Snyder SH. Dawson TM, et al. Among authors: dawson vl. Ann Neurol. 1992 Sep;32(3):297-311. doi: 10.1002/ana.410320302. Ann Neurol. 1992. PMID: 1384420 Review.

3

Functional recovery of supersensitive dopamine receptors after intrastriatal grafts of fetal substantia nigra.

Dawson TM, Dawson VL, Gage FH, Fisher LJ, Hunt MA, Wamsley JK. Dawson TM, et al. Among authors: dawson vl. Exp Neurol. 1991 Mar;111(3):282-92. doi: 10.1016/0014-4886(91)90095-t. Exp Neurol. 1991. PMID: 1825638

4

Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.

Dawson TM, Dawson VL, Gage FH, Fisher LJ, Hunt MA, Wamsley JK. Dawson TM, et al. Among authors: dawson vl. Brain Res. 1991 Feb 1;540(1-2):145-52. doi: 10.1016/0006-8993(91)90501-l. Brain Res. 1991. PMID: 1905173 Free article.

5

Muscarinic and dopaminergic receptor subtypes on striatal cholinergic interneurons.

Dawson VL, Dawson TM, Wamsley JK. Dawson VL, et al. Among authors: dawson tm. Brain Res Bull. 1990 Dec;25(6):903-12. doi: 10.1016/0361-9230(90)90186-4. Brain Res Bull. 1990. PMID: 2149667

6

Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase.

Nelson RJ, Demas GE, Huang PL, Fishman MC, Dawson VL, Dawson TM, Snyder SH. Nelson RJ, et al. Among authors: dawson vl, dawson tm. Nature. 1995 Nov 23;378(6555):383-6. doi: 10.1038/378383a0. Nature. 1995. PMID: 7477374

7

Nitric oxide as a mediator of neurotoxicity.

Dawson TM, Dawson VL, Snyder SH. Dawson TM, et al. Among authors: dawson vl. NIDA Res Monogr. 1993;136:258-71; discussion 271-3. NIDA Res Monogr. 1993. PMID: 7507221 Review. No abstract available.

8

Neuroprotective effects of gangliosides may involve inhibition of nitric oxide synthase.

Dawson TM, Hung K, Dawson VL, Steiner JP, Snyder SH. Dawson TM, et al. Among authors: dawson vl. Ann Neurol. 1995 Jan;37(1):115-8. doi: 10.1002/ana.410370122. Ann Neurol. 1995. PMID: 7529474

9

Cyclic nucleotide dependent phosphorylation of neuronal nitric oxide synthase inhibits catalytic activity.

Dinerman JL, Steiner JP, Dawson TM, Dawson V, Snyder SH. Dinerman JL, et al. Neuropharmacology. 1994 Nov;33(11):1245-51. doi: 10.1016/0028-3908(94)90023-x. Neuropharmacology. 1994. PMID: 7532810

10

Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures.

Dawson VL, Brahmbhatt HP, Mong JA, Dawson TM. Dawson VL, et al. Among authors: dawson tm. Neuropharmacology. 1994 Nov;33(11):1425-30. doi: 10.1016/0028-3908(94)90045-0. Neuropharmacology. 1994. PMID: 7532825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

415 results

Search Page

Filters